ASCP Technologist in Immunology (I) Practice Exam

When rheumatoid factor is present in a patient's serum, it can lead to a false positive result for the detection of IgM class antibodies. This occurs because rheumatoid factor is often an IgM antibody itself that targets the Fc portion of IgG antibodies, including those that may be used in immunoassays designed to detect IgM.

The presence of rheumatoid factor can cross-react with the detection systems that are used to measure IgM, resulting in readings that show IgM antibodies where there may not be any true positive signal. This is particularly critical in testing for various conditions, such as autoimmune diseases, where accurate antibody detection is essential for diagnosis and management.

The other choices are not as likely to occur. False negatives for IgG or IgM antibodies are generally less influenced by the presence of rheumatoid factor. Incorrect interpretation related to IgA antibodies is also less common, as the mechanisms and pathways of detection for IgA differ from those used in the detection of IgM. Thus, the marked impact of rheumatoid factor on IgM detection makes it clear why the correct answer is related to false positives in that context.